menu
    • menu

    Company profile for Regor Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, China and Boston, USA. Our current therapeutic areas of interest include oncology, metabolic diseases and autoimmune diseases. By leveraging our industry-leading core strength in CA...
    Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, China and Boston, USA. Our current therapeutic areas of interest include oncology, metabolic diseases and autoimmune diseases. By leveraging our industry-leading core strength in CARD (Computer Accelerated Rational Discovery), Regor is committed to creating a highly efficient ecosystem for accelerated discovery of innovative therapeutic agents with differentiated therapeutic values.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Regor TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 Main Street, Second Floor, Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regor.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sermonix & Regor Collaborate to Optimize rCARD Platform
    Sermonix & Regor Collaborate to Optimize rCARD Platform

    24 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sermonix-and-regor-announce-strategic-collaboration-to-optimize-regors-proprietary-rcard-platform-for-identification-of-novel-targets-and-therapeutics-302409362.html

    PR NEWSWIRE
    24 Mar 2025
    Share Share
    Regor Begins Phase 2b US Study for RGT-075 in Treating Obesity
    Regor Begins Phase 2b US Study for RGT-075 in Treating Obesity

    10 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regor-releases-phase-2a-topline-results-for-rgt-075-an-oral-once-daily-small-molecule-glp-1r-agonist-and-begins-phase-2b-study-in-the-us-for-the-treatment-of-obesity-302348153.html

    PR NEWSWIRE
    10 Jan 2025
    Share Share
    Regor, Genentech to Acquire Regor's Portfolio for CDK of Breast Cancer
    Regor, Genentech to Acquire Regor's Portfolio for CDK of Breast Cancer

    30 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regor-enters-into-a-definitive-purchase-agreement-for-genentech-to-acquire-regors-portfolio-of-next-generation-cdk-inhibitors-for-the-treatment-of-breast-cancer-302262174.html

    PR NEWSWIRE
    30 Sep 2024
    Share Share
    Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075
    Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075

    08 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regor-initiates-phase-2-study-of-oral-once-daily-glp-1-agonist-rgt-075-for-the-treatment-of-obesity-302084213.html

    PR NEWSWIRE
    08 Mar 2024
    Share Share
    Regor Announces Safety And Single Agent Efficacy Data Evaluating RGT-419B
    Regor Announces Safety And Single Agent Efficacy Data Evaluating RGT-419B

    07 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regor-announces-promising-safety-and-single-agent-efficacy-data-evaluating-rgt-419b-in-hrher2--advanced-breast-cancer-patients-who-have-progressed-on-cdk46-inhibitors-and-endocrine-therapy-302009555.html

    PR NEWSWIRE
    07 Dec 2023
    Share Share
    Regor notches minor victory in trade secrets feud with Pfizer
    Regor notches minor victory in trade secrets feud with Pfizer

    08 Feb 2023

    // Fraiser Kansteiner FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/regor-gets-permission-glimpse-pfizers-fbi-communique-glp-1-trade-secrets-dispute

    Fraiser Kansteiner FIERCE BIOTECH
    08 Feb 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search